Mark Hallen's Colleagues at Gavilán Biodesign
Mark Hallen's Contact Details
N/A
Gavilán Biodesign
Mark Hallen's Company Details
Ten63 Therapeutics is a venture-backed startup focused on improving human health by developing better, more durable therapeutics against some of the world's most lethal diseases. We are leveraging our proprietary in silico technology to hit previously undruggable targets while bringing the paradigm of durable response into early drug design. We achieve this through a unique platform that is capable of searching unprecedented chemical and comformational space with highly accurate physics based models. Our platform allows us to challenge diseases to a chess match, one that is played through evolutionary time. The result are novel therapeutics that are resilient to the emergence of drug resistance and able to modulate previously undruggable targets. We are an innovative, young, motivated and highly technical team on a mission to improve human health. We started building our pioneering in silico drug design technology in Bruce Donald's lab at Duke University, and we have published over 50 papers related to it. At Ten63, we want a better world with healthier people! We value passion, teamwork, out of the box thinking and determination to solve even what seems impossible. We embrace diversity and are committed towards inclusion. If you think you have what it takes to be a part of out team, please apply.